Fig. 9

A schematic diagram representing the role of AGAP2-AS1 in breast cancer chemoresistance via upregulating MyD88 expression through modifying H3K27 acetylation
A schematic diagram representing the role of AGAP2-AS1 in breast cancer chemoresistance via upregulating MyD88 expression through modifying H3K27 acetylation